XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) EV to FCF (2023)

Updated

XORTX Therapeutics' EV to FCF came in at 271.32 for the quarter ended Dec 31, 2023.

Analysis

XORTX Therapeutics (XRTX) EV to FCF (2023) Analysis & Trends

Over the trailing twelve months to Dec 31, 2023, XORTX Therapeutics reported EV to FCF of -4168.91; for the year ended Dec 31, 2021, it was 34.45.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 271.32
API Access

XORTX Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=XRTX&period=max&api_key=YOUR_API_KEY